The Closing Bell: Navigating Today's Final Trades with BABA, ZM, NVO, and TJX
Novo Nordisk's Alzheimer's Trial Setback: A Closer Look
The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp
Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal
The GLP-1 Revolution: Why the Market's Reaction to Novo Nordisk and Eli Lilly is Lagging
The Final Verdict: Top Stock Picks Poised for Growth